| Mckenzie Davis Sameshima, DPT | |
|
12500 Dallas Pkwy, Frisco, TX 75033-4229 | |
| (469) 604-9000 | |
| (469) 604-9001 |
| Full Name | Mckenzie Davis Sameshima |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 12500 Dallas Pkwy, Frisco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841755071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 1314597 (Texas) | Primary |
| 225100000X | Physical Therapist | 1314597 (Texas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
Engineers often use nature to inspire new materials and designs. A discovery by a multi-institutional team of researchers and engineers about how tendon and bone attach in the shoulder joint has uncovered previously unsuspected engineering strategies for attaching dissimilar materials.
A pioneering new system codeveloped by Sinai Hospital orthopedic surgeons Shawn Standard, M.D., head of Pediatric Orthopedics at the International Center for Limb Lengthening (ICLL), and John Herzenberg, M.D., director of the ICLL, offers a major advancement in limb lengthening surgery.
Bacteria play a role in myriad industrial processes from fermentation to cleaning up environmental pollution. But floating freely in solution, the microbial cells constantly multiply, generating biomass that must be removed periodically, causing downtime. Additionally, the microorganisms cannot be localized to a specific region of interest.
› Verified 9 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
Engineers often use nature to inspire new materials and designs. A discovery by a multi-institutional team of researchers and engineers about how tendon and bone attach in the shoulder joint has uncovered previously unsuspected engineering strategies for attaching dissimilar materials.
A pioneering new system codeveloped by Sinai Hospital orthopedic surgeons Shawn Standard, M.D., head of Pediatric Orthopedics at the International Center for Limb Lengthening (ICLL), and John Herzenberg, M.D., director of the ICLL, offers a major advancement in limb lengthening surgery.
Bacteria play a role in myriad industrial processes from fermentation to cleaning up environmental pollution. But floating freely in solution, the microbial cells constantly multiply, generating biomass that must be removed periodically, causing downtime. Additionally, the microorganisms cannot be localized to a specific region of interest.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mckenzie Davis Sameshima, DPT Po Box 2650, Coppell, TX 75019-8650 Ph: (972) 724-2400 | Mckenzie Davis Sameshima, DPT 12500 Dallas Pkwy, Frisco, TX 75033-4229 Ph: (469) 604-9000 |
News Archive
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
Engineers often use nature to inspire new materials and designs. A discovery by a multi-institutional team of researchers and engineers about how tendon and bone attach in the shoulder joint has uncovered previously unsuspected engineering strategies for attaching dissimilar materials.
A pioneering new system codeveloped by Sinai Hospital orthopedic surgeons Shawn Standard, M.D., head of Pediatric Orthopedics at the International Center for Limb Lengthening (ICLL), and John Herzenberg, M.D., director of the ICLL, offers a major advancement in limb lengthening surgery.
Bacteria play a role in myriad industrial processes from fermentation to cleaning up environmental pollution. But floating freely in solution, the microbial cells constantly multiply, generating biomass that must be removed periodically, causing downtime. Additionally, the microorganisms cannot be localized to a specific region of interest.
› Verified 9 days ago
Johanna Elizabeth Hogan, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 16061 Coit Rd, Frisco, TX 75035 Phone: 469-219-2300 | |
Jessica Dabis, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5700 Dallas Pkwy, Frisco, TX 75034 Phone: 469-515-7158 | |
Dr. David C. Lo, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5100 Fax: 469-888-5222 | |
Dr. Laura C. Schick, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2895 Bandolier Ln, Frisco, TX 75034 Phone: 972-841-6628 | |
Fernando Rios Trevino, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5700 Dallas Pkwy, Frisco, TX 75034 Phone: 469-515-7222 | |
Anna V Chavez, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5200 | |
Benjamin R. Selbo, D. P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5000 Eldorado Pkwy Ste 430, Frisco, TX 75033 Phone: 214-436-4606 Fax: 214-436-4794 |